| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-02-01 | FY 2023
FILED 2024-02-03 |
|---|---|---|---|
| Revenue (Total Sales) | $1.00B | $1.10B | $1.15B |
| YoY Revenue Growth % | -9.4% | -4.2% | — |
| Gross Profit | $348.0M | $413.5M | — |
| Gross Margin % | 34.8% | 37.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $21.4M | $57.2M | $57.1M |
| Operating Margin % | 2.1% | 5.2% | 5.0% |
| Net Income (GAAP) | -$7.0M | $16.3M | $11.6M |
| EBITDA (Normalized) | $28.5M | $68.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$13.0M | $77.4M | $42.8M |
| Capital Expenditures (CapEx) | $8.9M | $14.4M | — |
| Free Cash Flow (FCF) | -$21.9M | $63.0M | $42.8M |
| FCF Margin % | -2.2% | 5.7% | 3.7% |
| Return on Invested Capital (ROIC %) | 74.0% | 95.0% | — |
| Cash & Short-Term Equivalents | $20.0M | $48.5M | — |
| Total Debt (Short + Long Term) | $256.3M | $272.4M | — |
| Total Stockholders' Equity | -$213.4M | -$191.1M | — |